Metraipolis › archive › dc_bd9531eee94a

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B… — Europe PMC PMID:42445187

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42445187
DOI
10.3389/fimmu.2026.1778330
License (as archived)
solo-consultazione
Archived
2026-10-31T07:24:56.645Z
SHA-256 of the archived text
0ee6ea376e1328ffb87f7751fc6d43fc80902c86809870bca315e9079a7c8d5b
Stable URL of this page
https://metraipolis.com/documento/dc_bd9531eee94a

How to cite

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B… — Europe PMC PMID:42445187 — Europe PMC (en), https://europepmc.org/article/MED/42445187 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd9531eee94a (Metraipolis archive dc_bd9531eee94a, sha256 0ee6ea376e1328ffb87f7751fc6d43fc80902c86809870bca315e9079a7c8d5b)
BibTeX
@misc{dcbd9531eee94a,
  title = {Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B… — Europe PMC PMID:42445187},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445187},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd9531eee94a; sha256 0ee6ea376e1328ffb87f7751fc6d43fc80902c86809870bca315e9079a7c8d5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445187. Agents can read the archived copy with the MCP tool read_document.